CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Scott Weiner to join panel at 2nd Annual Global Healthcare Investing Conference
News | 04. 30. 2008
